A Targeted Personalized Approach
Lantern is disrupting, reinventing and de-risking the traditional cancer drug development process by employing an adaptive 3R strategy: Rescue, Reposition and Revitalize abandoned drugs by harnessing the power of advanced genomics and artificial intelligence, also applicable for placing new drugs.
Partner With Us
We are a multi-national company committed to technology-driven drug candidate advancement. Join us in this mission.